Thrombocytopenia News and Research

RSS
Thrombocytopenia is a condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues.
FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

New collaboration aims to prevent life-threatening adverse reactions to medications

New collaboration aims to prevent life-threatening adverse reactions to medications

USC research could lay foundation for a vaccine against tick-borne virus

USC research could lay foundation for a vaccine against tick-borne virus

Oral drug used to treat blood clots in cancer patients appears to be safe and effective

Oral drug used to treat blood clots in cancer patients appears to be safe and effective

New clinical practice guidelines for managing venous thromboembolism released

New clinical practice guidelines for managing venous thromboembolism released

FDA approves new treatment for AML patients

FDA approves new treatment for AML patients

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus announces availability of Arsenic Trioxide Injection in the US

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

CNIO researchers link MASTL protein to origin of thrombocytopenia

CNIO researchers link MASTL protein to origin of thrombocytopenia

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Study suggests new approach to treat life-threatening blood disorder in children

Study suggests new approach to treat life-threatening blood disorder in children

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

Researchers discuss clinical application of bivalirudin in interventional cardiovascular procedures

Researchers discuss clinical application of bivalirudin in interventional cardiovascular procedures

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia